Buy Now: Magnetic Resonance Imaging Market

KEY TAKE AWAYS

  • To define and measure the MRI market and its various sub-segments with respect to technology, hybrid technology and applications.
  • To identify the major drivers  and restraints of the market
  • To identify and analyze comprehensively the market structure with respect to the factors influencing the market growth and industry specific challenges.
  • To analyze the trends and forecasts of the  MRI  market and its segments
  • To identify the major stakeholders in the market and draw a competitive landscape for the market leaders
  • To analyze the opportunities in the market for the stakeholders
  • To strategically analyze micro markets with respect to their individual growth trends, future prospects and contribution to the total market
  • To understand the regulatory framework , patient safety and pricing issues of  MRI  market
  • To analyze and forecast the revenues of market segments with respect to geographies (North America, Europe, Asia and Rest of the World)
  • To identify the drug delivery technology and recent drug delivery techniques in   MRI market
  • To provide comprehensive analysis of the top players in MRI market competitive scenario of the same market.
  • To identify and analyze the competitive scenario and importance of attributes of the MRI systems from the end users to provide comprehensive market understanding.

REPORT DESCRIPTION

The global MRI market is witnessing a rapid growth and is expected to maintain the same trend in the future due to its wide application of MRI in clinics and health care centres. Demand for effective diagnosis has given raise to the need for enhanced data image provided by MRI imaging system, especially in cardiovascular diseases, thereby increasing the market revenues.

Installation of the MRI imaging systems in the medical institutions promises increased ROI for the health care providers. As the major of the medical institutions are exploring new ways to cut down the expenditure due to the worldwide economic downturn, the healthcare providers are looking for speedy and advanced solution. This in turn increases the overall patients’ turnaround, thereby increasing revenues for healthcare providers. Functional MRI, therefore is preferred for improved and speedy diagnosis.

This report highlights the major MRI market by modality, component, technology and also the major application market of the MRI. The submarkets for the modality, technology, components and applications will also be analyzed in depth in the report. Our analysis would help the industry players to get acquainted with the upcoming trends, opportunities and hiccups in the market along with a detailed analysis of the sub-markets as well. The report will size all the sub markets and also give a detailed geographic split among the four major markets of North America, Europe, Asia and Rest of the World. We will provide market trends and forecasts supported by the drivers and inhibitors for each sub-segment. More than 50 market tables and top company profiles will provide a deeper insight into the market and the competitive landscape as well. We will categorize market tables into geographic regions, products, applications and technology.

In addition to the market size, data trends and forecasts, the report will also highlight key opportunity areas for the relevant stakeholders. We will analyze new product launches in the MRI market and sub markets. In addition, we will analyze and profile key market developments of the top companies in this market and its sub-segments while drawing a competitive landscape for major markets and their sub segments.

MARKETS COVERED

The key markets we cover are:

  • MRI market by   modality (Closed MRI systems, Open MRI systems, High field MRI systems, Medium field MRI systems, Low field MRI systems)
  • MRI market by  component (Magnets, RF Systems, MRI Gradient Coils, MRI Scanner, MRI software market ,Others)
  • MRI market by technology (MR angiogram, MR venogram, Functional MRI, NMR spectroscopy, Others ((Perfusion MRI, Diffusion MRI, Voxel-based morphometry, MR spectroscopic imaging))
  • MRI market by application (Whole body MRI, Interventional MRI, MRI for brain and neurological disorders, Breast MRI, Cardiac MRI, Others)

STAKEHOLDERS

  • MRI and medical imaging manufacturers
  • MRI and medical imaging suppliers and distributors
  • Associations
  • Research and strategic consulting firms

Buy Now: Magnetic Resonance Imaging Market

TABLE OF CONTENT

1. MRI MARKET OVERVIEW

(MRI total market is expected to cross $ 5.3 billion by 2010. Demand for interventional MRI, cardiac MRI and whole-body MRI are escalating the current market revenues, however, the functional imaging capabilities of MRI is expected to drive the future market.)

1.1. Market definition and evolution
1.2. Supply side analysis and demand side analysis (methodology and process)
1.3. Present and emerging market analysis (Market growth and relative share matrix)
1.4. Market impact analysis: Impact of market shift towards functional MRI.
1.5. Key findings
1.5.1. Supply side analysis
1.5.2. Demand side analysis
1.6. Competitive scenario: GE, Siemens, Philips, leading the market
1.7. Opportunity analysis:
- Opportunities in next generation diagnostic capability MRI
- Asian markets for MRI are growing at higher rate than the global market.
1.8. Emerging demands: Need for real time imaging process.
1.9. Technology adoption analysis
1.10. Geographical trends: U.S. leading the market, however Japan also holds significant
1.11. Pricing analysis
1.12. Strategic recommendations

SUPPLY SIDE ANALYSIS FOR PET MARKET
2. MRI market by modality

(The high field MRI systems market is to exceed above $ 1 billion  by 2010. The need for sophisticated technologies and enhanced capabilities is driving the healthcare providers to upgrade and replace existing equipments.)

2.1. Market overview
2.2. Market Estimates (2009 to 2014) (By Product and By Geography)
2.2.1. Unit shipment
2.2.2. Average price
2.2.3. Market revenues
2.3. Market Trends
2.3.1. Market drivers
2.3.2. Restraints
2.3.3. Opportunities
2.4. Gap analysis
2.5. Market share and competitive landscape
2.6. Strategic analysis
2.7. Market segmentation by modality (All the above factors will be discussed for each of the market segment discussed below)
2.7.1. Closed MRI systems
2.7.2. Open MRI systems
2.7.3. High field MRI systems
2.7.4. Medium field MRI systems
2.7.5. Low field MRI systems

3. MRI market segmentation by component

3.1. Market overview
3.2. Market Estimates (2009 to 2014) (By Product and By Geography)
3.2.1. Average price
3.2.2. Market revenues
3.3. Market Trends
3.3.1. Market drivers
3.3.2. Restraints
3.3.3. Opportunities
3.4. Gap analysis
3.5. Competitive landscape
3.6. Strategic analysis
3.7. Market segmentation by MRI components (All the above factors will be discussed for each of the market segment discussed below)
3.7.1. MRI RF Systems
3.7.2. MRI Gradient Coils
3.7.3. MRI Scanner
3.7.4. MRI software market
3.7.5. Other components

4. MRI market segmentation by technology

(Functional MRI remains a significant market, due to increasing number of research to study the human brain across universities. Higher Tesla rates to drive the market for need of enhanced image quality.)

4.1. Market overview
4.2. Market Estimates (2009 to 2014) (By Geography)
4.2.1. Average price
4.2.2. Market revenues
4.3. Market Trends
4.3.1. Market drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Gap analysis
4.5. Strategic analysis
4.6. Market segmentation by MRI technology (All the above factors will be discussed for each of the market segment discussed below)
4.6.1. MR angiogram
4.6.2. MR venogram
4.6.3. Functional MRI
4.6.4. NMR spectroscopy
4.6.5. Others (Perfusion MRI, Diffusion MRI, Voxel-based morphometry, MR spectroscopic imaging)

5. MRI market segmentation by application

(Current market illustrates demand for musculoskeletal and abdomen imaging, however, procedural volumes are expected to increase for breast and cardiac MRI in the future.)

5.1. Market overview
5.2. Market Revenue (2009 to 2014) (By Geography)
5.3. Market Trends
5.3.1. Market drivers
5.3.2. Restraints
5.3.3. Opportunities
5.4. Gap analysis
5.5. Strategic analysis
5.6. Market segmentation by application  (All the above factors will be discussed for each of the market segment discussed below)
5.6.1. Whole body MRI
5.6.2. Interventional MRI
5.6.3. MRI for brain and neurological disorders
5.6.4. Breast MRI
5.6.5. Cardiac MRI
5.6.6. Others

DEMAND SIDE ANALYSIS

(Hospitals, healthcare providers, clinics etc will be contacted to track the below aspects)

5.7. Buying criteria
5.7.1. Price
5.7.2. Image quality
5.7.3. User friendliness
5.7.4. Application capabilities
5.7.5. Attributes impacting top line revenues
5.7.6. Attributes impacting bottom line revenues
5.7.7. Level of discounts
5.7.8. Level of infrastructure available at healthcare provider’s facility
5.7.9. Quality and durability
5.7.10. Post sale services
5.7.11. Budget allocation
5.7.12. Competition level among healthcare providers
5.7.13. Qualified resources
5.7.14. Others
5.8. Competitor benchmarking
5.8.1. Competitive Benchmarking – Strategic
5.8.1.1. Focus areas of the competitors in key segments
5.8.1.2. Expansion- M&A, geographic, investments, patents
5.8.1.3. Investing opportunities in new technologies
5.8.2. Competitive Benchmarking – Commercially
5.8.2.1. New Contracts signed  for past two years
5.8.2.2. Pricing level and discounting policy
5.8.2.3. Business models between product/ service provides and hospitals/ clinics
5.8.2.4. Pricing policies (skimming price, competitive pricing etc)
5.8.3. Competitive Benchmarking – Operational strength
5.8.3.1. Distribution channel model and analysis
5.8.3.2. Number of Employees
5.8.3.3. Operating units
5.8.3.4. Volume production
5.8.3.5. Roadmap and expansion – commercial portfolio
5.8.4. Competitive Benchmarking – Technical
5.8.4.1. Image quality
5.8.4.2. User friendliness
5.8.4.3. Technology innovation cycle
5.8.4.4. Durability
5.8.4.5. Speedy performance
5.8.4.6. Application capabilities
5.8.4.7. Others

STRATEGIC CONCLUSIONS

5.9. Key findings
5.10. Gap Analysis
5.11. Competitive Analysis
5.12. Geographic Analysis
5.12.1. North America
5.12.2. Europe
5.12.3. Asia Pacific
5.12.4. Rest of the world
5.13. Patent Analysis

APPENDIX:

List of patents
Decision Support Data
Number of hospitals
Number of hospital beds
Population over 60
Number of skilled resources
Medical device budget allocation (average)
Volume procedures

Company profiles (Sample)

1. GE Healthcare
2. Siemens Medical Solutions
3. Philips Medical Systems
4. Toshiba Medical Systems Corp
5. Medtronic Surgical Navigation Technologies
6. Medinus
7. IMRIS
8. Hitachi Medical Corporation
9. Fonar Corp
10. Esaote SPA

Buy Now: Magnetic Resonance Imaging Market

Magnetic Resonance Imaging (MRI) MARKET

MRI system is one of the booming sectors in the medical imaging information system market.  The combination of magnetic field and radio waves to provide enhanced images of the human anatomy is driving the installation of MRI systems among the end users (diagnostic centers, hospitals). MRI system market is expected to witness enormous growth due to innovations that are largely focused on enhancing image quality and escalating cost saving among the end users.

Key Trends

  • Significant demand can be expected from the dedicated MRI system due to the benefits offered in terms of image quality and cost effectiveness.
  • Continuous enhancement in Tesla strength of the MRIs is expected to provide a desired boost in the growth of the global MRI market.
  • Higher Tesla rates are preferred as they indicate high quality and enable quick inspection.

Geographic analysis

  • U.S:  U.S. forms the largest market segment both in unit and dollars terms. More than 50% of the MRI sales are contributed by High field MRIs in the U.S.
  • Asia: Japan MRI market remains saturated with significant current market revenues. However, the MRI market is emerging in regions such as India, China, Singapore and it is expected to poise a higher growth rate thus providing a lucrative opportunity to the MRI manufacturers and vendors.
  • Europe: EU countries have dedicated healthcare budgets. However, the current volumes, especially in Eastern Europe are not very significant keeping in mind the market potential. This offers significant opportunities for players focusing European markets.

The replacement of existing MRI units forms the largest segment as the effective life of these systems is 7 years. This is resulting in significant sales from replacement buyers. However due to huge cost associated, budget conscious end users postpone replacement to about 12 years, thereby adding up to the maintenance cost.

Figure 1:

Buyer Demand (%) of MRI Systems for the year 2009

Magnetic Resonance Imaging

Source: Markets and Markets

The top three players in this segment are GE Healthcare, Siemens Medical Solutions, and Philips Medical. The other key market participants are Toshiba Medical Systems Corp, Medtronic Surgical Navigation Technologies, Hitachi Medical Corporation, etc.

Buy Now: Magnetic Resonance Imaging Market

Posted by: marketsandmarkets | November 13, 2009

Diagnostic ECG Market (2009 – 2014)

Original Source: Diagnostic ECG Market

Buy Now: Diagnostic ECG Market

KEY TAKE AWAYS

  • To define global diagnostic ECG market and its sub markets.
  • To analyze intensively market dynamics and factors that drives and inhibits market growth.
  • To identify and analyze trends, gaps and opportunities in each of the market segments.
  • To analyze and forecast revenues of market segments with respect to geographies (North America, Europe, Asia & Rest of the World).
  • To strategically profile and analyze market players and their core competencies in diagnostic ECG market.
  • In-depth analysis of competitive scenario and key strategies followed by market players in the diagnostic ECG market.
  • To track and analyse recent developments, alliances, joint ventures, mergers & acquisitions in the industry.
  • To keenly analyze the market from demand perspective pertaining to attributes and competitor benchmarking.

REPORT DESCRIPTION

It is estimated that in the U.S. almost 2400 deaths per day occur due to cardiovascular disease. This astonishing figure due to the proportion of aged baby boomers present in the U.S. Although the cardiologists have managed to reduce the cardiac related deaths by 25 percent during the past 10 years yet the need for this continues to grow by 62% percent in the next 16 years particularly for baby boomers. These trends are expected to boost the demand of the DECG systems as it is expected to play the major role in achieving the desired goal. The DECG systems are gaining a global acceptance among the healthcare providers as it enables them to monitor the cardiac patients more efficiently which is one of the pre requisite for the high risk cardiac patients thereby boosting the demand.

Each of the section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 30 market tables for various geographic regions covering sub segments and micro markets. In addition the report also provides more than 40 profiles of key companies in the diagnostic ECG market segment.

STAKEHOLDERS

The intended audience includes

  • Medical imaging manufacturers, suppliers and dealers
  • Medical imaging software providers
  • Healthcare associations
  • Strategic consulting firms
Original Source: Diagnostic ECG Market

Buy Now: Diagnostic ECG Market

TABLE OF CONTENT

1. DIAGNOSTIC ECG MARKET OVERVIEW
1.1. Market definition and evolution
1.2. Supply side analysis and demand side analysis (methodology and process)
1.3. Present and emerging market analysis (Market growth and relative share matrix)
1.4. Market impact analysis: Impact of increased adoption of electronic health records among the healthcare institutes.
1.5. Key findings
1.5.1. Supply side analysis
1.5.2. Demand side analysis
1.6. Competitive scenario: GE and Philips remain dominant players in the market
1.7. Opportunity analysis:
- Extensive scope for product differentiation
- Significant opportunities for vendors providing integrated and end to end solution.
1.8. Emerging demands: Increasing need for remote and real time data access
1.9. Technology adoption analysis
1.10. Geographical trends
1.11. Pricing analysis: Price remains comparatively rigid as market players are capitalizing on product positioning and differentiation.
1.12. Strategic recommendations

SUPPLY SIDE ANALYSIS FOR DIAGNOSTIC ECG MARKET

2. DECG market segmentation by modality
2.1.1. Market overview
2.1.2. Market Estimates (2009 to 2014) (By Geography)
2.1.2.1. Unit shipment
2.1.2.2. Average price
2.1.2.3. Market revenues
2.1.3. Market Trends
2.1.3.1. Market drivers
2.1.3.2. Restraints
2.1.3.3. Opportunities
2.1.4. Gap analysis
2.1.5. Market share and competitive landscape
2.1.6. Strategic analysis
2.1.7. Product segmentation (All the above factors will be discussed for each of the products segmentation discussed below)
2.1.7.1. Electrocardiographs
2.1.7.2. Holter monitoring
2.1.7.3. Stress Testing and event monitoring
2.1.7.4. ECG data management systems
2.1.7.5. Defibrillators
2.1.7.6. Diagnostic ECG software

DEMAND SIDE ANALYSIS

(Hospitals, healthcare providers, clinics etc will be contacted to track the below aspects)

2.2. Buying criteria
2.2.1. Price
2.2.2. Quality (performance and imaging)
2.2.3. User friendliness
2.2.4. Attributes impacting top line revenues
2.2.5. Attributes impacting bottom line revenues
2.2.6. Level of discounts
2.2.7. Level of infrastructure available at healthcare provider’s facility
2.2.8. Durability
2.2.9. Post sale services
2.2.10. Budget allocation
2.2.11. Competition level among healthcare providers
2.2.12. Qualified resources
2.2.13. Others
2.3. Competitor benchmarking
2.3.1. Competitive Benchmarking – Strategic
2.3.1.1. Focus areas of the competitors in key segments
2.3.1.2. Expansion- M&A, geographic, investments, patents
2.3.1.3. Investing opportunities in new technologies
2.3.2. Competitive Benchmarking – Commercially
2.3.2.1. New Contracts signed  for past two years
2.3.2.2. Pricing level and discounting policy
2.3.2.3. Business models between product/ service provides and hospitals/ clinics
2.3.2.4. Pricing policies (skimming price, competitive pricing etc)
2.3.3. Competitive Benchmarking – Operational strength
2.3.3.1. Distribution channel model and analysis
2.3.3.2. Number of Employees
2.3.3.3. Operating units
2.3.3.4. Volume production
2.3.3.5. Roadmap and expansion – commercial portfolio
2.3.4. Competitive Benchmarking – Technical
2.3.4.1. Quality of performance and image
2.3.4.2. User friendliness
2.3.4.3. Technology innovation cycle
2.3.4.4. Durability
2.3.4.5. Speedy performance
2.3.4.6. Application capabilities
2.3.4.7. Others

STRATEGIC CONCLUSIONS

2.4. Key findings
2.5. Gap Analysis
2.6. Competitive Analysis
2.7. Geographic Analysis
2.7.1. North America
2.7.2. Europe
2.7.3. Asia
2.7.4. Rest of the world
2.8. Patent Analysis

APPENDIX:

List of patents
Decision Support Data
Number of hospitals
Number of hospital beds
Population over 60
Number of skilled resources
Medical device budget allocation (average)
Volume procedures

Company profiles (Sample)

1. Philips
2. Siemens
3. GE
4. Del Mar Medical
5. Control-X Medical
6. Compumed, Inc.
7. Cardio Perfect, Inc.
8. Applied Cardiac Systems, Inc
9. Cambridge Heart, Inc.
10. Arrhytmia Research Technology, Inc.
11. Brentwood Medical Products, Inc.
12. Biomedical Systems Corp
13. Aerotel Medical Systems
14. Cardionics, Inc.
15. Advanced Biosensor
16. Cardioline USA, Inc

Original Source: Diagnostic ECG Market

Buy Now: Diagnostic ECG Market

Diagnostic ECG (DECG) System Market

The DECG system market is mainly driven by the benefits offered by the DECG systems in terms of effective diagnosis with respect to cardiovascular disorders. The integrated systems enable efficiency through streamlining work flow and eliminating the probability of data loss. Apart from serving as crucial diagnostic tool DECG also enables the end users to provide effective service to the patients in terms administration and business operations as well.

Key trends

  • Aging baby boomers are driving the DECG market as they are more prone to the cardiovascular diseases.
  • Major demand of the integrated and complete DECG system is from the large size health care providers.
  • ECG data management systems segment is expected to poise a high growth rate in the coming future.
  • Market participants are capitalizing on product differentiation through brand attributes and positioning.
  • Market is expected to witness a high demand for the Holter monitoring systems from the medium size health care providers and dedicated cardiac clinics.

Geography analysis:

Figure 1

GEOGRAPHICAL SHARE (%) PERCENTAGE FOR THE DECG SYSTEMS MARKET

Diagnostic ECG

Source: Markets and Markets

  • U.S., Europe and Japan accounts the major market share in Holter monitoring segment
  • Asia Pacific expected to poise a high growth rate in coming future
  • Compared to other regions, EU is expected to account major market share for DECG systems market.

Figure. 2

MARKET REVENUE FORECAST FOR THE ECG DATA MANAGEMENT SYSTEM SEGMENT FOR THE YEAR (2009-2014)

DECG systems market

Source: Markets and Markets

The total market for ECG data management system was estimated to be around $126 million and is expected to reach around $151 million by 2014. The demand for ECG data management systems is fuelled by the need to streamline work flow and maintain electronic records.

Original Source: Diagnostic ECG Market

Buy Now: Diagnostic ECG Market

Posted by: marketsandmarkets | November 13, 2009

Positron Emission Tomography (PET) Market

Buy Now: Positron Emission Tomography (PET) Market

KEY TAKE AWAYS

  • To define and measure global PET market in detail with respect to technology and application.
  • To identify and analyze comprehensively the market structure with respect to the factors influencing the market growth and industry specific challenges.
  • To strategically analyze markets with respect to their individual growth trends, future prospects and contribution to the total market
  • To analyze and forecast the revenues of market segments with respect to geographies (North America, Europe, Asia and Rest of the World)
  • To strategically analyze and summarize the core competencies, product and service portfolio, recent developments and alliances of the market players in each of the sub-segments.
  • To draw demand analysis to clearly analyze and benchmark the attributes and competitors from the end user’s perspective.

REPORT DESCRIPTION

There is significant increase in the global demand of the PET procedure in last three years which has boost the demand of the PET scanners and this trend is expected to continue in the near future. The advent of the PET CT and PET SPECT has further enhanced the functionality of the scanners for the radiologists, thus making the images easier to interpret in more user friendly format. The procedure volume increased significantly due to the PET scanner approval for diagnosis of lung cancer, breast imaging, and colon cancer. The market is significantly active towards technological innovations thereby limiting the scope of product differentiation. This compels the market participants to understand the competitive scenario to effectively meet the needs of the end users.

This market report will enable strategic understanding on the PET market. Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 50 market tables and about 40 company profiles. . The report will size all the sub markets and also give a detailed geographic split among the four major markets of North America, Europe, Asia and Rest of the World

MARKETS COVERED

The key markets covered in the report:

  • PET market by technology (SPECT, PET/CT, hybrid technology – SPECT/CT)
  • PET market by application (Oncology, Cardiology, Neurology, Others)

STAKEHOLDERS

  • PET manufacturers
  • PET suppliers and dealers
  • Nuclear medicine  associations
  • Research and strategic consulting firms

Buy Now: Positron Emission Tomography (PET) Market

TABLE OF CONTENTS

1)  Global PET Market overview

(PET procedure volume to exceed 2 million procedures by 2010. The emerging markets in diagnosing myocardial viability and early diagnosis of Alzheimer’s are expected to raise the market significantly)

1.1. Market definition and evolution
1.2. Supply side analysis and demand side analysis (methodology and process)
1.3. Present and emerging market analysis (Market growth and relative share matrix)
1.4. Market impact analysis: Impact of reducing price per unit and increased acceptance of technology
1.5. Key findings
1.5.1. Supply side analysis
1.5.2. Demand side analysis
1.6. Competitive scenario: Siemens, Philips, GE leading the market
1.7. Opportunity Analysis:
- Market consolidation in U.S. and opportunities in emerging economies
- Increasing unit shipments of PET mobile units.
1.8. Emerging demands: Application in early diagnosis of Alzheimer’s disease and others
1.9. Technology adoption analysis
1.10. Geographical trends: U.S. leading the market, widening opportunities in Asia Pacific.
1.11. Pricing analysis
1.12. Strategic recommendations

SUPPLY SIDE ANALYSIS FOR PET MARKET

2. PET market segmentation by technology

(PET/CT remains the key technology earning the highest revenues. Multi-slice PET/CT with enhanced the functionality is demanded among the radiologist for as the images are easier to interpret. U.S. accounts for more than 65% of the total SPECT market. )

2.1. Market overview
2.2. Market Estimates (2009 to 2014) (By Technology and By Geography)
2.2.1. Unit shipments
2.2.2. Average price
2.2.3. Market revenues
2.3. Market Trends
2.3.1. Market drivers
2.3.2. Restraints
2.3.3. Opportunities
2.4. Gap analysis
2.5. Market share and competitive landscape
2.6. Strategic analysis
2.7. PET segmentation (technology): (Each of the factors discussed above will be covered under the market segments discussed below)
2.7.1. SPECT
2.7.2. PET/CT
2.7.3. Hybrid technology: SPECT/CT

3. PET market segmentation by application

(PET application in Oncology remains the highest with its share over 90%. However, escalating research in neurology is widening opportunities for PET market.)

3.1.1. Market Overview
3.1.2. Market Estimates (2009 to 2014) (By Application and By Geography)
3.1.2.1. Unit shipments
3.1.2.2. Market revenues
3.1.3. Market Trends
3.1.3.1. Market drivers
3.1.3.2. Restraints
3.1.3.3. Opportunities
3.1.4. Gap analysis
3.1.5. Market shares and competitive landscape
3.1.6. End user analysis
3.1.7. Strategic analysis
3.1.8. Application market (Each of the factors discussed above will be covered under the market segments discussed below)
3.1.8.1. Oncology
3.1.8.2. Cardiology
3.1.8.3. Neurology
3.1.8.4. Others

DEMAND SIDE ANALYSIS

(Hospitals, healthcare providers, clinics etc will be contacted to track the below aspects)

1.1. Buying criteria
1.1.1. Price
1.1.2. Image quality
1.1.3. User friendliness
1.1.4. Application capabilities
1.1.5. Attributes impacting top line revenues
1.1.6. Attributes impacting bottom line revenues
1.1.7. Level of discounts
1.1.8. Level of infrastructure available at healthcare provider’s facility
1.1.9. Quality and durability
1.1.10. Post sale services
1.1.11. Budget allocation
1.1.12. Competition level among healthcare providers
1.1.13. Qualified resources
1.1.14. Others
1.2. Competitor benchmarking
1.2.1. Competitive Benchmarking – Strategic
1.2.1.1. Focus areas of the competitors in key segments
1.2.1.2. Expansion- M&A, geographic, investments, patents
1.2.1.3. Investing opportunities in new technologies
1.2.2. Competitive Benchmarking – Commercially
1.2.2.1. New Contracts signed  for past two years
1.2.2.2. Pricing level and discounting policy
1.2.2.3. Business models between product/ service provides and hospitals/ clinics
1.2.2.4. Pricing policies (skimming price, competitive pricing etc)
1.2.3. Competitive Benchmarking – Operational strength
1.2.3.1. Distribution channel model and analysis
1.2.3.2. Number of Employees
1.2.3.3. Operating units
1.2.3.4. Volume production
1.2.3.5. Roadmap and expansion – commercial portfolio
1.2.4. Competitive Benchmarking – Technical
1.2.4.1. Image quality
1.2.4.2. User friendliness
1.2.4.3. Technology innovation cycle
1.2.4.4. Durability
1.2.4.5. Speedy performance
1.2.4.6. Application capabilities
1.2.4.7. Others

STRATEGIC CONCLUSIONS

1.1. Key findings
1.2. Gap Analysis
1.3. Competitive Analysis
1.4. Geographic Analysis
1.4.1. North America
1.4.2. Europe
1.4.3. Asia
1.4.4. Rest of the world
1.5. Patent Analysis

APPENDIX:

List of patents
Decision Support Data
Number of hospitals
Number of hospital beds
Population over 60
Number of skilled resources
Medical device budget allocation (average)
Volume procedures

Company profiles

1. GE Healthcare
2. Philips Medical Systems
3. Siemens Medical
4. Toshiba America Medical Systems
5. Gamma Medica
6. Mallinckrodt
7. Naviscan PET Systems
8. TeraRecon
9. CTI Molecular Imaging Inc.
10. MedImage Inc.
11. Positron Corporation

Buy Now: Positron Emission Tomography (PET) Market

 

Positron Emission Tomography (PET) MARKET

Propelled by the favorable reimbursement policies, new emerging markets such as Alzheimer’s and continuing expanding oncology application segment, the global PET market is expected to reach around $2.2 billion by 2010. Reimbursement plays a major role in the adoption of any medical imaging technology particularly among the outpatient imaging centers and mobile PET scanners service providers, as the scope of overhead cost spread is not as conveniently as large hospitals.

In 2007 the reimbursement in the U.S. for the PET- CT was around $950 which was increased to $1,057 in 2008. The approval of PET scanning reimbursement in the U.S. by the Medicare and Medicaid for the Alzheimer’s disease widened the opportunities for the major market participants. Currently there are approximately 4.7 million Alzheimer’s patients in the U.S.  PET enables the radiologist to have the early diagnosis of the Alzheimer disease among the patients. Therefore this would further increase the demand of the PET scanners among the various health care centers.

Figure 1

PET APPLICATION MARKET SHARE IN PERCENTAGE
Positron Emission Tomography

Source: Markets and Markets

Favorable reimbursements provided for the PET scanners would act as a catalyst in the growth of the market. Oncology continues to be the money spinning segment in the global PET application market.

>Figure 2

DEMAND FORECASTING BY THE TYPE OF THE BUYER

Positron Emission Tomography (PET)

Source: Markets and Markets

KEY TRENDS

  • Favorable reimbursement is boosting the demand of the PET scanners
  • Emerging application in Alzheimer’s diagnosis is expected to drive the future market.
  • Extended applications in Oncology market
  • Technology innovation in PET-CT, SPECT-CT to focus on advanced diagnosis tools
  • Wide acceptance of Hybrid technologies such as SPECT-CT
  • The dominance of high priced multi-slice PET-CT’s
  • Increased demand of SPECT from Non radiologist and Non -nuclear medicine Physicians

Owing to the increased R.O.I. provided by the PET-CT, SPECT, more and more Healthcare providers are expected to invest in Fixed PET-CT scanners in spite of using the services of a mobile PET- CT.

Buy Now: Positron Emission Tomography (PET) Market

 

Buy Now: Outsourcing Opportunities in the Medical Device

Report Description

Medical devices form one of the largest industries in healthcare sector with an estimated size of $250 billion in 2009 and a growth rate of 6%-8%. The industry has been outsourcing medical device manufacturing services for almost a decade now. This trend has brought about huge profit margins, which has attracted many new players. Outsourcing has helped medical device manufacturers reduce product development cost by 10% to 30%. The services outsourcing industry has also gained from the entry of new medical device manufacturing companies, as these players lack experience in the field.

Orthopedic devices hold the largest market share and cardiology devices have the highest growth rate in the medical device manufacturing industry. The increasing regulations for class 2 and class 3 devices have increased the demand for regulatory consulting services. Growing complexities in supply chain and the need for efficient management of client accounts have increased the scope of product lifecycle management solution providers in the medical devices industry. Firms offering chip designing services have also benefitted from the increasing incidence of chronic diseases and the growing use of electronic and embedded systems in cardiovascular and neurology devices.

The report analyzes the outsourcing opportunities in cardiovascular, ophthalmic, oncology, dental, and neurology devices, along with a study of various tools used for developing, testing and simulation tools used for medical devices. The report categorizes the service outsourcing in medical device market as follows:

Services Market: Product design and development services, product testing and certification services, product implementation services, product maintenance services, product upgrade services and Regulatory consulting services for medical devices.

Applications Market: Class I Devices, Class II Devices and Class III Devices.

STAKEHOLDERS

The intended audience includes:

  • Service outsourcing companies
  • Medical devices manufacturers
  • Consulting companies
  • Financial institutions

What makes our reports unique?

  • We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 4.
  • Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 200 patents and minimum 40 micro markets, which are collectively exhaustive and mutually exclusive.
  • No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – North America, Europe, Asia Pacific and ROW.
  • We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • 15 pages of high level analysis including benchmarking strategies, best practices (five level of products) and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

Key questions answered

  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies

Buy Now: Outsourcing Opportunities in the Medical Device

Table of contents

Executive summary
Market overview
Global services outsourcing in medical devices market Trends
Opportunities
Global services outsourcing in medical devices, by Applications
Opportunities
Global services outsourcing market in medical devices, by services
Global services outsourcing in medical devices market, geography Analysis
Global services outsourcing in medical devices market, competitive landscape

1. Introduction
1.1. KEY TAKE AWAYS
1.2. Report description
1.3. STAKEHOLDERS
1.4. Research Methodology

2. Summary

3. Market overview
3.1. Market overview
3.2. Industry Life Cycle
3.3. Defining Service Outsourcing in Medical Device Market

4. Market Dynamics
4.1. Outsourcing market dynamics
4.1.1. Drivers
4.1.1.1. Increasing competition is driving the demand for outsourcing services
4.1.1.2. Growing demand for quality healthcare strengthening the service  outsourcing market
4.1.1.3. Leveraging external expertise increasing
4.1.1.4. Reduced time-to-market offering competitive edge
4.1.1.5. Increased product recalls demanding better design and testing services
4.1.1.6. Growing Asian markets offer huge opportunities
4.1.2. Opportunities
4.1.2.1. Growing trend towards obtaining certification among service providers in Asian regions
4.1.2.2. Increasing Government participation to secure intellectual property rights

5. Applications market
5.1. market Overview
5.2. Drivers
5.2.1.1. Reducing product life span
5.2.1.2. Increasing demand for healthcare for low cost medical devices
5.2.1.3. Enhancement in healthcare technologies is driving the market for advanced medical devices
5.2.1.4. Threat from low cost manufacturers
5.2.1.5. Inconsistent regulations across globe increasing demand for regulatory consulting services
5.2.2. Restraints
5.2.2.1. Multiple outsourcing partners
5.2.2.2. Fear of loosing trade secrets restricting the outsourcing market growth
5.2.2.3. Lack of certified outsourcing partners
5.2.3. Opportunites
5.2.3.1. Emerging Asian markets
5.2.3.2. Growing trend towards outsourcing of IT services
5.2.4. Class III medical devices
5.2.4.1. Drivers
5.2.4.1.1. Critical devices demand more accurate and reliable design
5.2.4.1.2. Increased incidences of chronic diseases
5.3. Class II medical devices
5.3.1. Driver
5.3.1.1. Stringent government regulations
5.3.1.2. Growing complexity in design
5.4. Class I medical DEVICE
5.4.1. Driver
5.4.2. Restraint
5.4.3. Opportunity
5.5. Comparitive Analysis of Service Outsourcing medical devces
5.6. Cardiovascular devices
5.6.1. Global presence of the Key players:
5.6.1.1. Opportunities
5.6.1.1.1. Growing incidences of cardiovascular diseases:
5.6.1.1.2. Rapidly evolving technology
5.7. OrthopAedic devices
5.7.1.1. Opportunities
5.7.1.2. Consolidations in outsourcing market
5.7.1.3. Increasing product recalls
5.8. ANESTHESIOLOGY DEVICES
5.8.1. Opportunities
5.8.1.1. Increasing use of software
5.8.1.2. Changing technology
5.9. Radiology devices
5.9.1. Opportunities
5.10. Neurology
5.10.1. Opportunites

6. Services Market
6.1. Market overview
6.1.1. Drivers
6.1.1.1. Outsourcing of designing services reduce the time required to build the product
6.1.1.2. Innovation and cost reduction
6.1.1.3. Leveraging external expertise
6.1.1.4. Emergence of one stop solution providers
6.2. Product design and development services
6.2.1.Drivers
6.2.1.1. Reduced time to market and innovative product design
6.2.1.2. Huge earning opportunities through IP rights
6.2.1.3. Growing trend towards concentrating on core competencies
6.2.2. Opportunities
6.2.2.1. Entry of new players in medical device manufacturing industry
6.3. Regulatory Consulting Services
6.3.1.1. Computer system validation services (CSV)
6.3.1.2. 510(K)
6.3.1.3. PMA ( Premarket approvals)
6.3.1.4. CE Marking
6.3.2. Drivers
6.3.2.1. Reduces time to obtain approvals
6.3.2.2. Geographic expansion improving demand for regulatory consulting
6.4. Product Testing Services
6.4.1.1. Reduces chances of product recalls
6.4.1.2. Automated testing improves time to market
6.4.2. Product Implementation services
6.4.2.1. Increasing automation in medical device manufacturing companies
6.5. Product upgrade services
6.5.1. Increasing trend towards outsourcing of R&D for existing products
6.6. Product Maintenance services

7. Competitive landscape
7.1. Overview

8. Geographic Analysis
8.1. Overview
8.2. North America
8.2.1. Intense competition and rapidly changing technology
8.2.2. Highly regulated market
8.2.3. Cost containment pressure from government.
8.2.4. Increasing pressure to meet regulatory standards applicable to manufacturing processes
8.3. Europe
8.4. Asia pacific
8.4.1. Setting up of SEZs (special economic Zones).
8.4.2. Initiatives towards intellectual property rights protection

9. Essential Certifications for Outsourcing
9.1. Overview
9.1.1. ISO 13485:2003
9.1.2. ISO 9001:2000
9.1.3. ISO 14971
9.1.4. FDA 21 CFR PART 820:

10. company profiles
10.1. Accellent
10.2. Avail Medical Product Inc.
10.3. Benchmark Electronics, Inc.
10.4. Claricode
10.5. Code Refinery
10.6. Epic System
10.7. Etq
10.8. Infosys
10.9. HCL
10.10. Intertech Engineering Associates Inc.
10.11. Lake Region Medical Ltd.
10.12. Lynuxworks
10.13. MDCI
10.14. MedTech Development
10.15. Medtech Group
10.16. Oracle
10.17. Patni Computer Systems Ltd.
10.18. Persistent Systems
10.19. Pilgrim Software Inc.
10.20. PTC
10.21. RTEmd
10.22. Sterling Tech Software
10.23. Toltec International
10.24. Wipro
Appendix

List of TableS

1. Summary Table   global services outsourcing market for medical devices, By services 2007-2014 ($ Millions)
2. Major players in medical devices and their product portfolio
3. Global Services outsourcing opportunities in medical devices market, By Products 2007-2014 ($ Millions)
4. Global Services outsourcing opportunities in medical devices market, By Geography 2007-2014 ($ Millions)
5. Global services outsourcing  in Class III medical devices, by Geography 2007-2014 ($ Millions)
6. Global services outsourcing opportunities in Class II medical devices market by geography by 2007-2014 ($ Millions)
7. Global services outsourcing opportunities in Class I medical devices market, by geography 2007-2014 ($ Millions)
8. Services outsourcing market in medical devices, By application 2007-2014 ($ Miilions)
9. Global presence of major cardiovascular device manufacturers
10. Global presence of key ORTHOPEDIC device manufacturers
11. Segmentation of global orthopaedic devices market
12. Service Outsouring provided by various outsourcing companies
13. Global services outsourcing opportunities in medical devices market by Services 2007-2014 ($ Millions)
14. Global services outsourcing opportunities in medical devices market, By Geography 2007-2014 ($ Millions)
15. Global Product design and development services outsourcing in medical devices, by geography 2007-2014 ($ Millions)
16. Global regulatory consulting services in medical devices market, by geography 2007-2014 ($ Millions)
17. Global product testing services outsourcing in medical devices market, by geography 2007-2014 ($ Millions)
18. Global product implementation services outsourcing in medical devices market, by geography 2007-2014 ($ millions)
19. Global Product UPGRADE services outsourcing opportunities in medical devices market, by geography 2007-2014 ($ millions)
20. Global Product maintenance services outsourcing opportunities in medical devices market, by geography 2007-2014 ($ Millions)
21. Strategic Alliance and partnerships (2007 – 2009)
22. New developments in service offering (2007-2009)
23. North American market for services outsourcing in medical devices 2007-2014
24. European market for services outsourcing in medical devices 2007-2014 ($ millions)
25. Asian Market for services outsourcing in medical devices 2007-2014 ($ Millions)
26. phthalmic Medical  Device List
27. Neurology Medical Devices List
28. Radiology Device List
29. Gastroenterology – Urology Medical Devices List
30. Hematology Medical devices list
31. Dental Medical Device List

List of FIGURES

1. Participants OF OUTSOURCING market in  Medical Devices  manufacturing
2. Product life cycle of a medical device
3. CHALLENGE – BENEFIT ANALYSIS FOR MEDICAL DEVICE MANUFACTURING
4. Industry Life Cycle of Service Outsourcing in medical devices
5. Global market for Service Outsourcing in medical devices, by application, (2009)
6. Global Service Outsourcing Market in Medical devices, By Geography (2009)
7. Drivers impacting outsourcing in medical devices
8. Impact of Time-to-market on revenues
9. FDA classification of Medical devices
10. Global market share of top 10 medical device manufcaturers
11. Medical device approval process
12. Comparative analysis of service outsourcing in medical devices
13. Global market share of top orthopaedic device manufacturers
14. Global market share of top medical radiology device manufacturers
15. Segmentation of global medical radiology devices market
16. Major services offered by outsourcing partners and benefits to manufacturers
17. Structure of strategic partnership in the industry
18. Global services outsourcing market in medical devices
19. North American Market for service outsourcing in medical devices
20. European market for service outsourcing in medical devices
21. European medical device market
22. Asian Market for service outsourcing in medical devices
23. Asia Medical device market split
24. Requirements for ISO 13485
25. Requirements for ISO 9001:2000
26. Risk Management Process

Buy Now: Outsourcing Opportunities in the Medical Device

Service Outsourcing Opportunities in the Medical Device Market

Medical devices form one of the largest industries in healthcare sector with an estimated size of $250 billion in 2009 and a growth rate of 6%-8%. The industry has been outsourcing medical device manufacturing services for almost a decade now. This trend has brought about huge profit margins, which has attracted many new players. Outsourcing has helped medical device manufacturers reduce product development cost by 10% to 30%. The services outsourcing industry has also gained from the entry of new medical device manufacturing companies, as these players lack experience in the field.

The medical device outsourcing market is classified into the applications and services submarkets. Applications market covers outsourcing in class1, class2 and class 3 medical devices; while the services market covers designing, prototyping, validation and verification, and regulatory consulting services. The report also analyzes the outsourcing opportunities in cardiovascular, ophthalmic, oncology, dental, and neurology devices, along with a study of various tools used for developing, testing and simulation tools used for medical devices.

Orthopedic devices hold the largest market share and cardiology devices have the highest growth rate in the medical device manufacturing industry. The increasing regulations for class 2 and class 3 devices have increased the demand for regulatory consulting services. Growing complexities in supply chain and the need for efficient management of client accounts have increased the scope of product lifecycle management solution providers in the medical devices industry. Firms offering chip designing services have also benefitted from the increasing incidence of chronic diseases and the growing use of electronic and embedded systems in cardiovascular and neurology devices.

The global services outsourcing market in medical devices is expected to be worth $26,770 million by 2014, growing at a CAGR of 13.9% from 2009 to 2014. Regulatory consulting and other services forms the fastest growing market with a CAGR of 15.1% from 2009 to 2014.

Buy Now: Outsourcing Opportunities in the Medical Device

Posted by: marketsandmarkets | November 4, 2009

Global Electroactive Polymers Market (2009 – 2014)

Original Source: Electroactive Polymers

Buy Now: Electroactive Polymers

Report description

Technological developments in the electronics and semiconductor industries have led to the creation of polymers that change shape on the application of voltage. The biggest application for electroactive polymers (EAPs) lies in their future use as actuators and sensors, which in turn opens up a huge spectrum of applications in the fields of electronics, healthcare, sensing, and solar energy generation. With the growing market for each of these applications, EAP is set to become a mainstream market in the next five years. However, the technical specifications for each application differ widely, and extensive research and investments are still needed for developing application-specific EAPs.

The global electroactive polymers product market is expected to be worth US$2.78 billion by 2014. The conductive plastics segment contributed 84% to the overall market in 2009, mainly due to its extensive application in electrostatic discharge and electromagnetic interference. As the EAP market is still in the early phase, it presents many advantages for the early movers. As there are not too many companies involved now, detailed knowledge of the competitors will be crucial for the success of each company.

Scope of the report

This report aims to identify and analyze products and applications that use electroactive polymers. The report has segmented the global electroactive polymers market as follows:

  • Electroactive Polymers Product Market: Conductive plastics, Inherently Conductive Polymers (IDPS) and Inherently Dissipative Polymers (IDPS)
  • Electroactive Polymers Applications Market: OLED, Capacitors, Batteries, Organic transistors, Sensors, Solar cells, Actuators, Textiles and fabrics, Electromagnetic interference (EMI), Electrostatic discharge (ESD), Antistatic packaging, Paints and coatings and others.
  • Electroactive Polymers Technology Market: ICPs doping technology, Benefits of ICPs and technical aspects of conductive plastics

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 45 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 30 company profiles for each of its sub-segments.

What makes our reports unique?

  • We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
  • Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
  • No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, RoW.
  • We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
  • Comprehensive market analysis for the following sectors: Pharmaceuticals, medical devices, biotechnology, semiconductor and electronics, energy and power supplies, food and beverages, chemicals, advanced materials, industrial automation, and telecom and it. we also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Original Source: Electroactive Polymers

Buy Now: Electroactive Polymers

Table of Contents

1. Introduction

2. Summary

3. Market Overview
3.1. Market definition
3.2. Evolution of Electro-active Polymers
3.3. Comparison of Electro-active Polymers with other competing materials

4. Types of Electro-active Polymers
4.1. Inherently Conductive Polymers (ICPS)
4.1.1. Types of ICPS
4.1.1.1. Polythiophenes
4.1.1.2. Polyanilines
4.1.1.3. Polypyrroles
4.1.1.4. Polyacetylenes
4.1.1.5. Polyphenylene Vinylene
4.1.1.6. Polyfluorenes
4.1.1.7. Polyphenylene Sulfide
4.1.1.8.Polynaphthalene
4.1.2. Doping Technologies for ICPS
4.1.2.1. Chemical
4.1.2.2. Electrochemical
4.1.2.3. Types of dopants
4.1.3. Technical aspects of ICPS
4.1.3.1. Molecular weight
4.1.3.2. Improvement of high temperature conductivity and thermal stability
4.1.3.3. Alloys and Blends of ICPS with resins
4.1.4. Benefits of ICPS
4.1.4.1. Conductivity
4.1.4.2. Electro-chromic effects
4.1.4.3. Electroluminescence
4.1.4.4. Photoconductivity
4.1.4.5. Thermo-chromic effects
4.2. Inherently Dissipative Polymers (IDPS)
4.3. Conductive Plastics
4.3.1. Types of Conductive Plastics
4.3.1.1. ESD/EMI Compounds
4.3.1.2. Antistatic Additives
4.3.1.3. Metal/carbon Fibers
4.3.1.4. Carbon Nanotubes
4.3.2. Technical aspects of Conductive Plastics
4.3.2.1. Blends of conductive plastics and powder coatings
4.3.2.2. Novel conductive additives
4.4. Others

5. Electrical configuration
5.1. Dielectric
5.2. Ionic

6. Major role applications
6.1. Actuators
6.2. Sensors

7. End-Applications of Electro-active Polymers
7.1. Light Emitting Diode
7.2. OLED
7.3. Capacitors
7.4. Batteries
7.4.1. Lithium Batteries
7.4.2. All-polymer battery
7.4.3. Button Battery
7.4.4. Automotive battery
7.4.5. Portable computer battery
7.5. Semiconductor Transistors
7.5.1. Silicon substrates
7.5.2. Organic/Plastic transistors
7.6. Sensors
7.6.1. Remotely readable sensors
7.6.2. Gas sensors
7.6.3. Odor sensors
7.6.4. Chemical sensors
7.6.5. Biosensors
7.7. Solar Cells
7.8. Electronic displays
7.8.1. Flat panel displays
7.8.2. CRT
7.9. Electromagnetic interference
7.10. Electrostatic discharge
7.11. Antistatic packaging
7.12. Plastics coated with electrostatic paints
7.13. Other upcoming applications

8. Geographic analysis
8.1. United States
8.2. Europe
8.3. Asia

9. Company Profiles
9.1. BTech Scientific
9.2. Agfa-Gevaert NV
9.3. Air Products & Chemicals
9.4. American Dye Source
9.5. BASF, Inc
9.6. Cambridge Display Technology
9.7. Central Corporation
9.8. Crosslink Polymer Research
9.9. Dupont Displays
9.10. Eeonyx
9.11. Fractal Systems
9.12. Kemet Capacitors
9.13. Klockner Pentaplast of America
9.14. LNP Engineering Plastics
9.15. Lubrizol Advanced Materials
9.16. Marktek, Inc
9.17. Merck KGAA-Darmstadt
9.18. Milliken Research Corporation
9.19. Nanogenesys
9.20. Ormegon Chemie
9.21. Panipol Ltd
9.22. Plastic Logic
9.23. Plextronics, Inc
9.24. Polymer Vision, Ltd
9.25. Polyone
9.26. Premix OY
9.27. Rieke Metals
9.28. RTP Company
9.29. H.C. Starck International
9.30. Sterling Fibers
9.31. Universal Display Corporation

10. Patents
10.1. U.S Patents
10.2. Europe Patents
10.3. Asia Patents

Original Source: Electroactive Polymers

Buy Now: Electroactive Polymers

Global Electroactive Polymers Market: Revolutionizing Automation World

The increasing need for greater sophistication in the automation industry and in electronics protection is driving the market for low-cost, lightweight, and low driving voltage materials. Advances in electronics and polymers manufacturing technology have given rise to the concept of electroactive polymers. These polymers began to be used as base materials for motion control and protective applications as the use of mechanical moving parts reduced efficiency and increased wear and tear. When compared with conventional motion-generating devices, electroactive polymers provide equally good efficiency and lower costs and power consumption.

The electroactive polymers market is segmented into conductive plastics, inherently conducting polymers and inherently dissipative polymers. The global electroactive polymers market was at $1.7 billion in 2008; and is expected to grow exponentially at a CAGR of 8.3% from 2009 to 2014 mainly due to the already existing demand for new applications be commercialized in the next five years.

The electroactive polymers market holds a lot of scope for improved material commercialization as it is still in its nascent stage, and as high temperature resisting polymers are yet to be developed. The expected applications of electroactive polymers, such as full-page displays and biomimetics, are expected to boost the overall market. The development and commercialization of new polymers would further widen EAP applications. The key players in the electroactive polymers market include Artificial Muscle, H.C. Starck, Panipol Oy, etc.

Intensive R&D efforts, early product commercialization, and the high absorption rate of electronic products made North America the dominant market in 2008. The region held a 64% share of the global electroactive polymers product market, followed by Europe with a 22% share in the same year.

Global Electroactive Polymers Market by Products, 2009

Electroactive Polymers

Source: MarketsandMarkets

In 2009, the conductive plastics submarket is expected to dominate the global electroactive polymers market with 84% share, mainly due to its extensive application in electrostatic discharge and electromagnetic interference.

The U.S. accounted for 41% of the total number of electroactive polymers patents filed worldwide between 2004 and September 2009. The region had the highest number of patents mainly due to the presence of major players in this region and increasing R&D for new applications.

Our analysis indicates that companies taking the first mover advantage by quick commercialization of applications with intensive R&D efforts for new polymers and applications will have an edge over their competitors. Agreements and collaborations as well as new product launches are some of the most popular strategies adopted by market players to stay ahead of the competition and to expand into new geographies.

Original Source: Electroactive Polymers

Buy Now: Electroactive Polymers

 

Table of Content

1. Introduction

2. Summary

3. Market Overview

3.1. Market definition

3.2. Evolution of Electro-active polymers

3.3. Comparison of Electro-active polymers with other competing materials

3.4. Driving factor analysis of EAP market

3.5. Relative potential matrix for EAP products

3.6. Global EAP market dynamics

4. Types of Electro-active Polymers

4.1. Inherently Conductive Polymers (ICPS)

4.1.1. Types of ICPS

4.1.1.1. Polythiophenes

4.1.1.2. Polyanilines

4.1.1.3. Polypyrroles

4.1.1.4. Polyacetylenes

4.1.1.5. Polyphenylene Vinylene

4.1.1.6. Polyfluorenes

4.1.1.7. Polyphenylene Sulfide

4.1.1.8. Polynaphthalene

4.1.2. Doping Technologies for ICPS

4.1.2.1. Chemical

4.1.2.2. Electrochemical

4.1.2.3. Types of dopants

4.1.3. Technical aspects of ICPS

4.1.3.1. Molecular weight

4.1.3.2. Improvement of high temperature conductivity and thermal stability

4.1.3.3. Alloys and Blends of ICPS with resins

4.1.4. Benefits of ICPS

4.1.4.1. Conductivity

4.1.4.2. Electro-chromic effects

4.1.4.3. Electroluminescence

4.1.4.4. Photoconductivity

4.1.4.5. Thermo-chromic effects

4.2. Inherently Dissipative Polymers (IDPS)

4.3. Conductive Plastics

4.3.1. Types of Conductive Plastics

4.3.1.1. ESD/EMI Compounds

4.3.1.2. Antistatic Additives

4.3.1.3. Metal/carbon Fibers

4.3.1.4. Carbon Nanotubes

4.3.2. Technical aspects of Conductive Plastics

4.3.2.1. Blends of conductive plastics and powder coatings

4.3.2.2. Novel conductive additives

5. Electrical configuration

5.1. Dielectric

5.2. Ionic

6. Applications of Electro-active Polymers

6.1. OLED

6.2. Capacitors

6.3. Batteries

6.3.1. Lithium Batteries

6.3.2. All-polymer battery

6.3.3. Button Battery

6.3.4. Automotive battery

6.3.5. Portable computer battery

6.4. Semiconductor Transistors

6.4.1. Silicon substrates

6.4.2. Organic/Plastic transistors

6.5. Sensors

6.5.1. Gas sensors

6.5.2. Odor sensors

6.5.3. Chemical sensors

6.5.4. Biosensors

6.6. Solar Cells

6.7. Actuators

6.8. Electronic displays

6.8.1. Flat panel displays

6.8.2. CRT

6.9. Electromagnetic interference

6.10. Textiles and Fabrics

6.11. Electrostatic discharge

6.12. Antistatic packaging

6.13. Plastics coated with electrostatic paints

6.14. Other upcoming applications

7. Geographic analysis

7.1. North America

7.2. Europe

7.3. Asia

7.4. RoW

8. Company Profiles

8.1. 3M

8.2. Abtech Scientific, Inc.

8.3. Agfa-Gevaert Group NV

8.4. American Dye Source, Inc.

8.5. Artificial Muscle

8.6. BASF, Inc

8.7. Beakert

8.8. Cabot Corporation

8.9. Cambridge Display Technology

8.10. Central Corporation

8.11. Chevron Philips

8.12. Cytec Industries Inc.

8.13. Danfoss

8.14. Discover Technologies Inc.

8.15. Eamex

8.16. Eeonoyx

8.17. Fractal System, Inc.

8.18. H.C. Starck International

8.19. Hyperion Catalysis International, Inc.

8.20. Kemet Corporation

8.21. Konarka Technologies, Inc.

8.22. Lubrizol Advanced Materials

8.23. Marktek

8.24. Medipacs LLC

8.25. Micromuscle AB

8.26. Ormegon Chemie

8.27. Panipol Ltd

8.28. Plextronics, Inc

8.29. Polyone

8.30. Premix OY

8.31. Rieke Metals, Inc

8.32. Rtp company

9. Patents

9.1. U.S. Patents

9.2. Europe Patents

9.3. Asia Patents

10. Appendix

Posted by: marketsandmarkets | November 4, 2009

Global Wireless and Mobile Backhaul Equipment Market (2009–2014)

Buy Now: wireless backhaul equipment market

The improvements in networking and modern-day communications have brought about the demand for bulk transfer of voice and data from one point separated from another by almost 50-100 miles. While the conventional wire-connected networks had great bandwidth, they involved the complex task of the stretching physical wires over great distances. In wireless data backhaul, data packets can be sent to distances as far as 50 miles at a speed ranging from 1Mbps to 2Gbps. Cellular operators have played an important role in this new emerging market of wireless data backhauling. The emergence of 3G services has provided biggest market boost, as these services provide organizations huge bandwidth for transferring data from one location to another.

The growing trend of globalization has been a pivotal factor in the market growth of telecommunications; and thus acts as a market driver for wireless data transfer and the wireless backhaul market as well. The economic growth of developing nations and the spread of internet and mobile communications in these regions have opened up new markets for wireless backhauling. The market is set for a huge growth as wireless backhaul is expected to become a mainstream technology for data transfer within the next five years.

The global wireless and mobile backhaul equipment market is expected to be worth US$38.0 billion by 2014, growing at an estimated CAGR of 18.7% from 2009 to 2014. Microwave forms the largest market segment and is expected to reach a size of US$16.5 billion by 2014. Asia is the largest wireless backhaul market; and is expected to be worth US$12.2 billion by 2014, accounting for nearly 32% of the total revenues. The Asian wireless backhaul market also has the highest CAGR of 21.8%.

Scope of the Report

This report aims to identify and analyze Global Wireless and Mobile Backhaul Equipment Market according to applications, technologies, and topologies. The report provides in-depth market estimates and forecasts for Global Wireless and Mobile Backhaul Equipment Market as follows:

  • Wireless and Mobile Backhaul Equipment Market– Technologies: TDM & ATM, microwave, pseudowire, free space optics, satellite, All-IP RAN
  • Wireless and Mobile Backhaul Equipment Market– Application: Voice/data backhaul between cellular towers, broadband backhaul connectivity, building-to-building connectivity, video surveillance backhaul
  • Wireless and Mobile Backhaul Equipment Market– Topologies: Point to Point (PTP) configurations, Point to Multipoint (PTM) configurations, wireline bridging and extension

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide various market tables for different geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 40 company profiles for each of its sub-segments.

What makes our reports unique?

  • We provide the longest market segmentation chain in this industry- not many reports provide market breakdown up to level 5.
  • Each report is about 250 pages with 50+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.
  • No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
  • We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

Key questions answered

  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Buy Now: wireless backhaul equipment market

Table of Contents

1. Introduction

2. Summary

3. Market Overview
3.1. Evolution of wireless backhaul
3.2. Impact analysis of affecting factors
3.3. Growing trends of 3G subscribers

4. Transport mechanisms for wireless backhaul
4.1. TDM Leased Lines
4.2. Microwave
4.3. All-IP RAN
4.4. Satellite
4.5. Multi-service systems using pseudo-wires
4.6. Free space optics
4.7. Asynchronous transfer mode (ATM)
4.8. Others

5. Network topologies for Backhaul
5.1. Point to point (PTP) configurations
5.2. Point to multipoint (PTM) configurations
5.3. Wireline bridging and extension
5.4. Comparative analysis
5.4.1. Operational cost comparison for PTP, PTM and wireline
5.4.2. Capital cost comparison for PTP, PTM and wireline
5.4.3. Performance comparison for PTP, PTM and Wireline
5.4.3.1. Bandwidth capacity
5.4.3.2. Reliability

6. Wave properties
6.1. Modulation
6.1.1. Phase-shift keying (PSK) modulation
6.1.2. Quadrature amplitude (QAM) modulation
6.2. Multiplexing
6.2.1. Frequency division multiplexing (FDM)
6.2.2. Time division multiplexing (TDM)
6.2.3. Orthogonal frequency division multiplexing ( OFDM)

7. Wireless backhaul- A challenging market for cellular operators
7.1. Increase in 3G service for backhaul
7.2. Reduction in cost per bit
7.3. Reduction in profitability
7.4. Challenges in maintaining operational cost
7.5. Challenge from the DSL service operators
7.6. Emerging threat from IP/Ethernet
7.7. Growing popularity of satellite backhaul
7.8. Limited spectrum availability for wireless backhaul

8. Applications
8.1. Voice/data backhaul between cellular towers
8.2. Broadband backhaul connectivity
8.3. Building-to-building connectivity
8.4. Video surveillance backhaul

9. Geographic Analysis
9.1. United States
9.2. Europe
9.3. Asia

10. Company Profiles
10.1. AT&T
10.2. Qwest
10.3. Verizon
10.4. Embarq
10.5. Windstream
10.6. Cox Communications
10.7. Time Warner Cable
10.8. Optimum Lightpath
10.9. Bright House Networks
10.10. Comcast
10.11. Charter
10.12. TW telecom
10.13. XO Communications
10.14. Level 3
10.15. Nortel
10.16. ADC Telecommunications
10.17. Sumitomo Electric Lightwave
10.18. ZTE Corporation
10.19. Harmonic
10.20. Shanghai Sun Telecom
10.21. Polatis
10.22. Diamond USA
10.23. Cisco Systems
10.24. Commscope
10.25. Anritsu
10.26. Cable Plus, LLC
10.27. LightComm Technology
10.28. Volex
10.29. Sunrise Opto Limited
10.30. Absolute Analysis
10.31. FiberTower

11. Patents
11.1. U.S Patents
11.2. Europe Patents
11.3. Asia Patents

Buy Now: wireless backhaul equipment market

Immense Opportunities in the Global Wireless and Mobile Backhaul Equipment Market

The growing trend of globalization has been a pivotal factor in the market growth of telecommunications; and thus acts as a market driver for wireless data transfer and the wireless backhaul market as well. The economic growth of developing nations and the spread of internet and mobile communications in these regions have opened up new markets for wireless backhauling. The market is set for a huge growth as wireless backhaul is expected to become a mainstream technology for data transfer within the next five years.

The global wireless and mobile backhaul equipment market is getting a boost mainly from the increasing adoption of third generation (3G) and fourth generation (4G) services and applications grow. The major challenges are the risks involved with high investment and the possibility of getting it obsolete as the technology keeps on changing. However, the opportunities for wireless and mobile backhaul equipment market are immense, as numbers of cell sites and wireless broadband are expected to grow in next few years.

The global wireless and mobile backhaul equipment market is expected to be worth US$38.0 billion by 2014, growing at an estimated CAGR of 18.7% from 2009 to 2014. Asia is the largest wireless backhaul market; and is expected to be worth US$12.2 billion by 2014, accounting for nearly 32% of the total revenues. The Asian wireless backhaul market also has the highest CAGR of 21.8%.

Global wireless and mobile backhaul equipment market by technologies, 2009

wireless backhaul equipment market

Source: MarketsandMarkets

Microwave backhaul technology is expected to form the largest market in 2009. This market is expected to account for 43% of the total backhaul technology market. This is mainly because of its use in European and Asian market on a large scale. TDM & ATM accounts for the second largest market as American market is still dominated by this technology only.

Our analysis indicates that companies offering technology that will reduce operational cost (OPEX) cost and simultaneously enhance the network performance will have an edge over competitors. Agreements and collaborations as well as new product launches are the most popular strategies adopted by market players to stay ahead of the competition and to expand into new geographies. The key players in wireless and mobile backhaul equipment market include Cisco Systems, DragonWave Inc, Embarq, Huawei, Nokia Siemens, Sprint Nextel, Ceragon and Ericssion.

Buy Now: wireless backhaul equipment market

Posted by: marketsandmarkets | October 30, 2009

Global Stem Cell and Advanced Technologies Market

Original Source: stem cell market

Buy Now: stem cell market

Report Description

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Market Estimates and Forecasts

The report categorizes the global stem cell market as follows:

  • Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types)
  • Stem Cell Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology )
  • Stem Cell Technologies (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture)
  • Stem Cell Applications (regenerative medicine – neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 35 company profiles for each of its sub-segments.

What makes our reports unique?

  • We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
  • We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
  • Comprehensive market analysis for the following sectors:

Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Original Source: stem cell market

Buy Now: stem cell market

Global Stem Cell and Advanced Technologies Market

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

 

Estimated size of stem cell market in 2009

stem-cell

 

Original Source: stem cell market

Buy Now: stem cell market

Table of contents

Executive summary
MARKET OVERVIEW
Stem cell market dynamics
OPPORTUNITIES
Stem cells product market
OPPORTUNITIES
Stem cells technology market
Stem cells services market
Stem cells applications market
Geographic analysis
Competitive landscape

1. INTRODUCTION
1.1. KEY TAKE-AWAYS
1.2. REPORT DESCRIPTION
1.3. Research METHODOLOGY
1.4. STAKEHOLDERS

2. Summary

3. market overview
3.1. Defining the stem cell market
3.2. Factors influencing the stem cells market
3.3. Stem cell market inhibitors
3.4. Regenerative medicine dominates stem cell applications
3.5. FACTORS INFLUENCING THE STEM CELLS MARKET
3.5.1. U.S. Liberal Politics
3.5.2. Guidelines for responsible stem cells research
3.5.3. European national policies and legal issues
3.5.4. E.U. funding for stem cells research
3.5.5. Asia Pacific
3.6. Stem cell patent analysis

4. Stem cell market dynamics
4.1. Drivers
4.1.1. Potential of stem cells in regenerative medicine
4.1.2. Key to anti-ageing and prolonging life
4.1.3. Increasing R&D INVESTMENTS in adult stem cell research
4.1.4. EASE of administration
4.1.5. Reduced risk of tissue rejection in transplants
4.1.6. Federal funding for stem cell research
4.2. Restraints
4.2.1. safety issues
4.2.2. Ethical issueS
4.2.3. minimal Insurance coverage
4.3. Opportunities
4.3.1. technological innovations
4.3.2. Emerging application as a drug discovery tool
4.3.3. other promising applications

5. Global stem cells product market
5.1. Stem cell classification on the basis of potency
5.2. Adult stem cells
5.2.1. Drivers
5.2.1.1. Applications in cancer and chronic disease treatment
5.2.1.2. Availability of adequate safety & efficacy evidence
5.2.1.3. Technology innovations
5.2.1.4. Lower costs & no ethical issues
5.2.2. Restraints & Opportunities
5.2.2.1. Lower therapeutic potential
5.2.2.2. Need for minimising intervention
5.2.3. Hematopoietic Stem Cells
5.2.3.1. Drivers & Restraints
5.2.3.1.1. Wide range of applications
5.2.3.1.2. Enhanced usage due to recent technology advancements
5.2.3.1.3. Underused treatment, ineffective GvHD management
5.2.4. Mesenchymal stem cells
5.2.4.1. Drivers
5.2.4.1.1. Huge potential of MSCs
5.2.4.1.2. Advantageous cell type for allogenic transplantation
5.2.4.2. Restraints & Opportunities
5.2.4.2.1. Low number of mesenchymal stem cells in bone marrow
5.2.4.3. Potential applications of MSC therapy
5.3. Embryonic stem cells
5.3.1. Drivers & REStraints
5.3.1.1. Immense potential due to pluripotent nature
5.3.1.2. Ban on federal funding lifted
5.3.1.3. Ethical issues and inadequate safety data
5.3.2. Umbilical cord stem cells
5.3.3. Neuronal stem cells
5.3.4. Dental stem cells
5.3.5. Other novel cell types

6. stem cells technology market
6.1. Stem cell production
6.1.1. Somatic nuclear transfer / Therapeutic cloning
6.1.2. IVF (In vitro fertilization)
6.1.3. Isolation & Cell culture
6.2. Expansion & Sub culture
6.3. Stem cell acquisition
6.3.1. Bone marrow harvest
6.3.2. Apheresis
6.3.3. Umbilical cord blood stem cells acquisition
6.4. Cryopreservation & storage

7. Global stem cells services market
7.1. Stem cell banking
7.1.1. Ethical issues on stem cell banking
7.2. Stem cell acquisition & testing
7.3. Characterization services
7.3.1. HLA typing services
7.3.2. Stem cell custom services
7.3.3. Stem cell custom antibody services
7.4. Molecular biology
7.5. Drug screening & target validation

8. Global stem cells applications market
8.1. Regenerative medicine
8.1.1. Drivers & Restraints
8.1.1.1. Simple and cost-effective production method
8.1.1.2. Public & political support
8.1.1.3. High cost of treatment and low reimbursements
8.1.2. Neurological disorders
8.1.2.1. Alzheimer’s disease
8.1.2.2. Parkinson’s disease
8.1.2.3. Multiple sclerosis
8.1.2.4. Others
8.1.3. Myocardial Infarction & cardiovascular diseases
8.1.4. Cancer
8.1.4.1. Breast cancer
8.1.4.2. Multiple myeloma
8.1.4.3. Other diseases
8.1.5. Injuries
8.1.6. Incontinence
8.1.7. Diabetes
8.1.8. Orthopedics
8.1.9. Liver disorders
8.1.10. Hematological disorders
8.1.10.1. Other applications
8.1.10.1.1. Limb Ischemia
8.1.10.1.2. Systemic lupus
8.2. Drug Discovery & Development

9. Geographic analysis
9.1. North America
9.2. Europe
9.3. Asia
9.4. ROW

10. Competitive landscape
Appendix
10.1. Government policies & guidelines
10.1.1. Patents for united states
10.1.2. Patents for europe
10.1.3. Patents for Japan

11. Company Profiles
11.1. Advanced Cell Technology Inc
11.2. Aldagen
11.3. Angel Biotechnology
11.4. Angioblast Systems Inc
11.5. Aastrom Biosciences Inc
11.6. Athersys
11.7. Bioheart Inc
11.8. Brainstorm Cell Therapeutics
11.9. California Stem Cell
11.10. Celgene Corporation
11.11. Cellartis AB
11.12. Cellerant Therapeutics
11.13. Cellular Dynamics International, Inc
11.14. Cellular Engineering Technologies
11.15. CordLife Ltd
11.16. Cytori Therapeutics Inc
11.17. ES Cell International
11.18. Gamida Cell Ltd
11.19. Genzyme Corporation
11.20. Geron Corporation Inc
11.21. Global Stem Inc
11.22. Intercytex (and its subsidiary Axordia)
11.23. Medistem Inc
11.24. Mesoblast Ltd
11.25. MultiCell Technologies, Inc
11.26. Neostem
11.27. Novocell Inc
11.28. NeuralStem Biopharmaceuticals, Ltd.
11.29. Opexa Therapeutics
11.30. Osiris Therapeutics, Inc
11.31. Plureon Corp
11.32. Pluristem Therapeutics
11.33. ReNeuron, Inc
11.34. StemCells, Inc
11.35. StemLifeLine
11.36. t2cure Gmbh
11.37. TheraVitae
11.38. Thermo Fisher Scientific Inc
11.39. Thermogenesis Corporation
11.40. VetCell Bioscience Ltd

List of TableS

SUMMARY TABLE  Global stem cell market 2009-2014 ($ thousands)
Table 1    Global stem cell market by product 2007-2014 ($ Millions)
Table 2    Global adult stem cell market by product 2007-2014 ($ Millions)
Table 3    Global other novel cell types market by product 2007-2014 ($ Millions)
Table 4    Global stem cell technology market 2007-2014 ($ Millions)
Table 5    Global stem cell production market by product 2007-2014 ($ Millions)
Table 6    Global stem cell acquisition market by product 2007-2014 ($ Millions)
Table 7    Global stem cell services market by product 2007-2014 $ Millions)
Table 8    Global characterization services market by product 2007-2014 ($ Millions)
Table 9    Global stem cell applications market by product  2007-2014 ($ Thousands)
Table 10 Global stem cell applications market by geography 2007-2014 ($ Millions)
Table 11 Global regenerative medicine market by product 2007-2014 ($ Millions)
Table 12 Global regenerative medicine market by geography 2007-2014 ($ Millions)
Table 13 Global neurological disorders market by geography  2007-2014 ($ Millions)
Table 14 Global Myocardial Infarction & cardiovascular diseases market by geography 2007-2014 ($ Millions)
Table 15 Global cancer market by geography 2007-2014 ($ Millions)
Table 16 Global Injuries market for stem cells by product 2007-2014 ($ Millions)
Table 17 Global Injuries market for stem cells by geography  2007-2014 ($ Millions)
Table 18 Global Incontinence market for stem cells by geography 2007-2014 ($ Millions)
Table 19 Global Diabetes  market by geography 2007-2014 ($ Millions)
Table 20 Global Orthopedics market in stem cells by geography 2007-2014 ($ Millions)
Table 21 Global Liver disorders market by geography 2007-2014 ($ Millions)
Table 22 Global Hematological disorders market by geography 2007-2014 ($ Millions)
Table 23 Global Other regenerative medicines market by geography 2007-2014 ($ Millions)
Table 24 Global Drug Discovery & Development market by geography 2007-2014 ($ Millions)
Table 28 New product, technology, service launch (2008-2009)
Table 29 List of agreements and collaborations (2008-2009)
Table 30 List of mergers and acquisition (2008-2009)

List of FIGURES

Figure 1 STEM CELL MARKET SEGMENTATION
Figure 2 Driving factors
Figure 3 Inhibitor matrix
Figure 4 Stem cell application market dynamics
Figure 5 RELATIVE IMPORTANCE OF FACTORS AFFECTING STEM CELL MARKET
Figure 6 NIH funding for stem cell research
Figure 7 patent analysis by geography 2006 to 2008
Figure 8 Patent analysis by segment 2006 to 2008
Figure 9 Patent analysis by competitors
Figure 10 Major market growth factors
Figure 11 Stem cell classification on the basis of potency
Figure 12 Stem cell technologies
Figure 13 Prominent focus areas in regenerative medicine
Figure 14 Stem cell transplants types
Figure 15 global Stem cells market by geography ($billion)
Figure 16 North American Stem cells market
Figure 17 european Stem cells market
Figure 18 asian Stem cells market
Figure 19 row Stem cells market
Figure 20 Major segments focused by global stem cell market players (2008-2009)
figure 21 Competitive landscape for collaborations (2008-2009)

Original Source: stem cell market

Buy Now: stem cell market

Posted by: marketsandmarkets | October 29, 2009

Growing opportunities in Global Biodiesel Market (2009-2014)

Original Source: Biodiesel market

Buy Now: Biodiesel market

KEY TAKE AWAYS

  • To define the global market for Global Biodiesel market
  • To measure the market size for the Global Biodiesel market and its sub-markets
  • To identify the major driving factors and inhibitors
  • To analyze the trends and forecasts of the main market and its segments
  • To identify the major stakeholders in the market and draw a competitive landscape for the market leaders
  • To analyze the trends and opportunities in major regions, viz. U.S, Europe, and Asia.

Report Description

Energy is one of the prime needs of mankind and several sources have been identified to meet this need. Petroleum had been the major source of energy for till date. But their limited availability and their surging prices have forced mankind to search for alternative fuels. Biodiesel had been one of the renewable fuels that have been developed and is contributing towards meeting the global demand for fuels. Biodiesel is renewable and is also independent of the price fluctuations in the conventional petroleum products. Another major advantage of Biodiesel is that they do not pollute the environment, in contrast to the non-renewable sources like petroleum. With the government of all the major nations taking initiatives to encourage the increasing usage of Biodiesel, this market is slated for a huge growth in the next few years. The surging prices for non-renewable source, petroleum in particular and growing concern over pollution-control is also helping the market for Biodiesel. Many countries have initiated blending of conventional diesel with some percentage of Biodiesel to enhance engine life and reduce pollution. With a huge opportunity in sight, companies are buzzing with huge investment in improving the conversion efficiency for the renewable sources and this will give the overall market a boost.

MARKETS COVERED

The major feedstocks like vegetable oils, Wasted Vegetable Oils, Algae and animal fats have been covered in great depth. We have also included in our report the various conversion processes like Transesterification, neutralization, phase separation, and purification. We have also included the different comparative analysis between conventional petroleum and Biodiesel. The various applications like automotive, aerospace, railways and heating have been extensively covered in our report. Each of the major and micro market includes detailed analysis of the market trends and forecast, affecting factors and their competitive landscape. We have done an in-depth geographic analysis for each of the markets and their sub-segments, covering the major regional markets, viz. U.S, Europe, Asia and Rest of the World.

STAKEHOLDERS

The intended audience of this report includes:

  • Biodiesel producers
  • Feedstock suppliers
  • Automotive manufacturers
  • Aerospace companies and organizations
  • Research labs
Original Source: Biodiesel market

Buy Now: Biodiesel market

Table of Contents

1. Introduction
2. Summary
3. Market Overview

3.1. Evolution of Biodiesel
3.2. Market definitions
3.3. Factors affecting the market and their impact analysis
3.4. Pricing trend analysis for Biodiesel

4. Types of biofuels
4.1. Biogas
4.2. Vegetable oils
4.3. Biodiesel
4.4. Syngas
4.5. Bioethanol
4.6. Fischer-Tropsch diesel
4.7. Bio-DME
4.8. DMF
4.9. Biomethanol
4.10. Biohydrogen
4.11. Wood diesel
4.12. Mixed alcohol
4.13. Others

5. Production of Biodiesel
5.1. Challenges with Biodiesel production
5.1.1. Land availability
5.1.2. Climatic issues
5.1.3. Technology developments
5.1.4. Government policies
5.2. Conversion steps from bio-oil to Biodiesel
5.2.1. Transesterification
5.2.2. Neutralization
5.2.3. Phase separation
5.2.4. Purification
5.3. Feedstocks
5.3.1. Vegetable oils
5.3.2. Waste Vegetable Oils
5.3.3. Animal fats
5.3.4. Algae
5.3.5. Others

6. Consumption of Biodiesel
6.1. Global petroleum demand trends and forecast analysis
6.2. Consumption trends and forecasts of Biodiesel
6.3. Blends with conventional diesel

7. Biodiesel Vs Conventional petroleum
7.1. Pricing
7.2. Environmental pollution
7.3. Energy output
7.4. Production capacities
7.5. Production costs
7.6. Government benefits and initiatives

8. Applications
8.1. Automotive
8.2. Aerospace
8.3. Railways
8.4. Heating
8.5. Others

9. Geographic Analysis
9.1. United States
9.1.1. Production trends and forecast of Biodiesel
9.1.2. Consumption trends and forecast of Biodiesel
9.1.3. Government initiatives to encourage Biodiesel
9.1.4. Government taxes and subsidization
9.1.5. Price difference between Biodiesel and conventional diesel
9.1.6. Supply Vs. Demand
9.2. Germany
9.2.1. Production trends and forecast of Biodiesel
9.2.2. Consumption trends and forecast of Biodiesel
9.2.3. Government initiatives to encourage Biodiesel
9.2.4. Government taxes and subsidization
9.2.5. Price difference between Biodiesel and conventional diesel
9.2.6. Supply Vs. Demand
9.3. France
9.3.1. Production trends and forecast of Biodiesel
9.3.2. Consumption trends and forecast of Biodiesel
9.3.3. Government initiatives to encourage Biodiesel
9.3.4. Government taxes and subsidization
9.3.5. Price difference between Biodiesel and conventional diesel
9.3.6. Supply Vs. Demand
9.4. Italy
9.4.1. Production trends and forecast of Biodiesel
9.4.2. Consumption trends and forecast of Biodiesel
9.4.3. Government initiatives to encourage Biodiesel
9.4.4. Government taxes and subsidization
9.4.5. Price difference between Biodiesel and conventional diesel
9.4.6. Supply Vs. Demand
9.5. United Kingdom
9.5.1. Production trends and forecast of Biodiesel
9.5.2. Consumption trends and forecast of Biodiesel
9.5.3. Government initiatives to encourage Biodiesel
9.5.4. Government taxes and subsidization
9.5.5. Price difference between Biodiesel and conventional diesel
9.5.6. Supply Vs. Demand
9.6. Brazil
9.6.1. Production trends and forecast of Biodiesel
9.6.2. Consumption trends and forecast of Biodiesel
9.6.3. Government initiatives to encourage Biodiesel
9.6.4. Government taxes and subsidization
9.6.5. Price difference between Biodiesel and conventional diesel
9.6.6. Supply Vs. Demand
9.7. Asia-Pacific
9.7.1. Production trends and forecast of Biodiesel
9.7.2. Consumption trends and forecast of Biodiesel
9.7.3. Government initiatives to encourage Biodiesel
9.7.4. Government taxes and subsidization
9.7.5. Price difference between Biodiesel and conventional diesel
9.7.6. Supply Vs. Demand
9.8. India-China
9.8.1. Production trends and forecast of Biodiesel
9.8.2. Consumption trends and forecast of Biodiesel
9.8.3. Government initiatives to encourage Biodiesel
9.8.4. Government taxes and subsidization
9.8.5. Price difference between Biodiesel and conventional diesel
9.8.6. Supply Vs. Demand
9.9. Rest of EU nations
9.9.1. Production trends and forecast of Biodiesel
9.9.2. Consumption trends and forecast of Biodiesel
9.9.3. Government initiatives to encourage Biodiesel
9.9.4. Government taxes and subsidization
9.9.5. Price difference between Biodiesel and conventional diesel
9.9.6. Supply Vs. Demand
9.10. Canada-Mexico
9.10.1. Production trends and forecast of Biodiesel
9.10.2. Consumption trends and forecast of Biodiesel
9.10.3. Government initiatives to encourage Biodiesel
9.10.4. Government taxes and subsidization
9.10.5. Price difference between Biodiesel and conventional diesel
9.10.6. Supply Vs. Demand
9.11. Rest of the World
9.11.1. Production trends and forecast of Biodiesel
9.11.2. Consumption trends and forecast of Biodiesel
9.11.3. Government initiatives to encourage Biodiesel
9.11.4. Government taxes and subsidization
9.11.5. Price difference between Biodiesel and conventional diesel
9.11.6. Supply Vs. Demand

10. Company Profiles
10.1. Ag Environmental Products, LLC
10.2. Archer Daniels Midland Company
10.3. ADM Hamburg AG
10.4. Ag Environmental Products, LLC
10.5. Archer Daniels Midland Company
10.6. ADM Hamburg AG
10.7. BDI BioDiesel International AG
10.8. Biodiesel Industries, Inc.
10.9. Environmental Alternatives LLC
10.10. Flint Hills Resources LP
10.11. Green Star Products, Inc.
10.12. American Biofuels
10.13. Griffin Industries
10.14. OceanAir Environmental LLC
10.15. Oelmuhle Hamburg AG
10.16. Organic Fuels LLC
10.17. Pacific Biodiesel, Inc.
10.18. Petroplus Holdings AG
10.19. Renewable Energy Group
10.20. Stepan Company
10.21. Topia Energy, Inc.
10.22. VERBIO Diesel Bitterfeld GmbH & Co. KG.
10.23. World Energy Alternatives

11. Patents
11.1. U.S Patents
11.2. EU Patents
11.3. Asia Patents

Original Source: Biodiesel market

Buy Now: Biodiesel market

Wilmington, Del.- The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Opportunity Analysis- H1N1 (Swine Flu) Vaccination Market (2009-2012) to be held on 3rd Nov 2009

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention.  Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations,  pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

To register your participation, please click here
http://www.marketsandmarkets.com/AnalystBriefing/swine-Flu-vaccination-market.asp
MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.

Ms. Sunita
108, West 13th Street,
Wilmington
DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com

H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009.  The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe.  H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918).

Review the complete report at: http://www.marketsandmarkets.com/PressReleases/swine-Flu-vaccination-market.asp

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention.  Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovac and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations,  pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011.

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.

Contact:
Ms. Sunita
108, West 13th Street,
Wilmington
DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com

Older Posts »

Categories